Peter Timmerman

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Timmerman. Retrieved from https://idiyas.com/inventor/peter-timmerman-kv40n131

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: The Innovations of Peter Timmerman

Introduction

Peter Timmerman is an accomplished inventor known for his contributions to the fields of protein chemistry, biology, and medicine. His work focuses on the design and preparation of protein mimics that have significant implications for therapeutic applications. Although he currently holds no patents, his innovative ideas have the potential to impact various medical fields.

Latest Patents

Peter Timmerman's latest patents include "Truncated Cystine-Knot Proteins," which relates to the design and preparation of protein mimics of members of the cystine-knot growth factor superfamily. This invention aims to utilize these protein mimics as medicaments or prophylactic agents. Another notable patent is "Binding Compounds, Immunogenic Compounds And Peptidomimetics Of The Beta-3 Hairpin Loop Of Cystine-Knot Growth Factors." This invention provides methods for producing compounds suitable for testing the presence and identification of immunogenic and binding compounds of interest.

Career Highlights

Peter Timmerman is currently associated with Pepscan Systems B.V., where he continues to explore innovative solutions in protein chemistry. His work at Pepscan Systems B.V. allows him to collaborate with other experts in the field and contribute to advancements in therapeutic compositions.

Conclusion

Peter Timmerman's innovative work in protein chemistry and biology showcases his potential to influence the medical field significantly. His focus on developing protein mimics and immunogenic compounds highlights the importance of research in creating effective therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…